Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
The Journal of Antimicrobial Chemotherapy
|
October 31, 2018
Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16
Laura Whitney, Hasan Al-Ghusein, Stephen Glass, et al.
Hematology/Oncology and Stem Cell Therapy
|
April 23, 2025
Framework for Patient Advocacy in Hematopoietic Cell Transplantation (HCT): An Overview from the Worldwide Network for Blood and Marrow Transplantation
Riad El Fakih, Cristobal Frutos, Carmem Bonfim, et al.
Experimental Hematology
|
June 28, 2011
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy
Madelaine Niam, Yeh-Ching Linn, Stephanie Fook Chong, et al.
British Journal of Clinical Pharmacology
|
July 14, 2020
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials
Emma H Baker, Kamal Patel, Jonathan Ball, et al.
Transfusion
|
November 24, 2018
Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant
Jeffrey Quek, Jing Jing Lee, Francesca Lorraine Lim, et al.
International Journal of Hematology
|
June 8, 2006
Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning
Su Ming Yvonne Loh, Pavanni Ratnagopal, Huat Chye Patrick Tan, et al.
Clinical Transplantation
|
January 31, 2017
Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population
Wei Zhou, Rehena Sultana, Colin Diong, et al.
Transfusion
|
October 16, 2020
Adverse event reporting for cellular therapy products: Current status and future directions
Kathy Loper, Michele W Sugrue, Jay S Raval, et al.
Cytotherapy
|
July 18, 2012
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission
Yeh-Ching Linn, Hao-Xiang Yong, Madelaine Niam, et al.
Annals of Hematology
|
December 19, 2014
WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients
Liyuan Ma, Siguo Hao, Colin Diong, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
The Journal of Antimicrobial Chemotherapy
|
October 31, 2018
Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16
Laura Whitney, Hasan Al-Ghusein, Stephen Glass, et al.
Hematology/Oncology and Stem Cell Therapy
|
April 23, 2025
Framework for Patient Advocacy in Hematopoietic Cell Transplantation (HCT): An Overview from the Worldwide Network for Blood and Marrow Transplantation
Riad El Fakih, Cristobal Frutos, Carmem Bonfim, et al.
Experimental Hematology
|
June 28, 2011
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy
Madelaine Niam, Yeh-Ching Linn, Stephanie Fook Chong, et al.
British Journal of Clinical Pharmacology
|
July 14, 2020
Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials
Emma H Baker, Kamal Patel, Jonathan Ball, et al.
Transfusion
|
November 24, 2018
Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant
Jeffrey Quek, Jing Jing Lee, Francesca Lorraine Lim, et al.
International Journal of Hematology
|
June 8, 2006
Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning
Su Ming Yvonne Loh, Pavanni Ratnagopal, Huat Chye Patrick Tan, et al.
Clinical Transplantation
|
January 31, 2017
Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population
Wei Zhou, Rehena Sultana, Colin Diong, et al.
Transfusion
|
October 16, 2020
Adverse event reporting for cellular therapy products: Current status and future directions
Kathy Loper, Michele W Sugrue, Jay S Raval, et al.
Cytotherapy
|
July 18, 2012
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission
Yeh-Ching Linn, Hao-Xiang Yong, Madelaine Niam, et al.
Annals of Hematology
|
December 19, 2014
WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients
Liyuan Ma, Siguo Hao, Colin Diong, et al.
Page
of 5